uniQure (QURE) Cash from Operations (2016 - 2026)
uniQure (QURE) posted quarterly Cash from Operations of 28576000.0 for Q2 2026, up 28.37% year-over-year from 22260310.07 in Q2 2025, and up 25.28% quarter-over-quarter from 38243000.0 in Q1 2026.
Analysis
uniQure (QURE) Cash from Operations (2016 - 2026) Analysis & Trends
uniQure's Cash from Operations history runs 11 years deep, the most recent figure standing at 28576000.0 for Q2 2026.
- In Q2 2026, Cash from Operations rose 28.37% year-over-year to 28576000.0; the TTM figure through Jun 2026 stood at 160787000.0 (up 7.29% YoY), while the FY2025 annual figure was 177963000.0, up 2.61% from the prior year.
- Cash from Operations for Q2 2026 stood at 28576000.0, up from 38243000.0 in the prior quarter.
- The five-year high for Cash from Operations was 38911000.0 in Q3 2023, with the low at 78302000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 41997500.0 (2025), against an average of 39916611.11.
- Peak annual rise in Cash from Operations reached 179.42% in 2023, while the deepest fall reached 263.55% in 2023.
- uniQure's Cash from Operations stood at 54680000.0 in 2022, then increased by 9.4% to 49541000.0 in 2023, then declined by 6.67% to 52844000.0 in 2024, then sank by 46.79% to 77569000.0 in 2025, then surged by 63.16% to 28576000.0 in 2026.
- Business Quant data shows QURE's Cash from Operations at 28576000.0 in Q2 2026, 38243000.0 in Q1 2026, and 77569000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -28.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.58 Mn |
| Mar 31, 2026 | -38.24 Mn |
| Dec 31, 2025 | -77.57 Mn |
| Sep 30, 2025 | -16.40 Mn |
| Jun 30, 2025 | -39.90 Mn |
| Mar 31, 2025 | -44.10 Mn |
| Dec 31, 2024 | -52.84 Mn |
| Sep 30, 2024 | -36.60 Mn |
| Jun 30, 2024 | -32.71 Mn |
| Mar 31, 2024 | -60.58 Mn |
| Dec 31, 2023 | -49.54 Mn |
| Sep 30, 2023 | 38.91 Mn |
| Jun 30, 2023 | -57.00 Mn |
| Mar 31, 2023 | -78.30 Mn |
| Dec 31, 2022 | -54.68 Mn |
| Sep 30, 2022 | -48.99 Mn |
| Jun 30, 2022 | -15.68 Mn |
| Mar 31, 2022 | -25.71 Mn |
| Dec 31, 2021 | -47.09 Mn |
| Sep 30, 2021 | -40.16 Mn |